Publications

A selection of recent and significant publications can be viewed below.

A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline for the Management of Hyperglycemia in Adults Hospitalized for Noncritical Illness or Undergoing Elective Surgical Procedures.: Seisa MO, Saadi S, Nayfeh T, Muthusamy K, Shah SH, Firwana M, Hasan B, Jawaid T, Abd-Rabu R, Korytkowski MT, Muniyappa R, Antinori-Lent K, Donihi AC, Drincic AT, Luger A, Torres Roldan VD, Urtecho M, Wang Z, Murad MH.; J Clin Endocrinol Metab (2022 Jul 14) 107:2139-2147. Abstract/Full Text
Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline.: Korytkowski MT, Muniyappa R, Antinori-Lent K, Donihi AC, Drincic AT, Hirsch IB, Luger A, McDonnell ME, Murad MH, Nielsen C, Pegg C, Rushakoff RJ, Santesso N, Umpierrez GE.; J Clin Endocrinol Metab (2022 Jul 14) 107:2101-2128. Abstract/Full Text
Enhancing the Trustworthiness of the Endocrine Society's Clinical Practice Guidelines.: McCartney CR, Corrigan MD, Drake MT, El-Hajj Fuleihan G, Korytkowski MT, Lash RW, Lieb DC, McCall AL, Muniyappa R, Piggott T, Santesso N, Schünemann HJ, Wiercioch W, McDonnell ME, Murad MH.; J Clin Endocrinol Metab (2022 Jul 14) 107:2129-2138. Abstract/Full Text
Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease.: Velenosi TJ, Ben-Yakov G, Podszun MC, Hercun J, Etzion O, Yang S, Nadal C, Haynes-Williams V, Huang WA, González-Hódar L, Brychta RJ, Takahashi S, Akkaraju V, Krausz KW, Walter M, Cai H, Walter PJ, Muniyappa R, Chen KY, Gonzalez FJ, Rotman Y.; Gastroenterology (2022 Jun) 162:1990-2003. Abstract/Full Text
Endogenous Leptin Concentrations Poorly Predict Metreleptin Response in Patients With Partial Lipodystrophy.: Meral R, Malandrino N, Walter M, Neidert AH, Muniyappa R, Oral EA, Brown RJ.; J Clin Endocrinol Metab (2022 Mar 24) 107:e1739-e1751. Abstract/Full Text
Minimal Model-Derived Insulin Sensitivity Index Underestimates Insulin Sensitivity in Black Americans.: Fosam A, Yuditskaya S, Sarcone C, Grewal S, Fan H, Muniyappa R.; Diabetes Care (2021 Nov) 44:2586-2588. Abstract/Full Text
Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals.: Gubbi S, Muniyappa R, Sharma ST, Grewal S, McGlotten R, Nieman LK.; J Clin Endocrinol Metab (2021 Apr 23) 106:1501-1515. Abstract/Full Text
When MINMOD Artifactually Interprets Strong Insulin Secretion as Weak Insulin Action.: Ha J, Muniyappa R, Sherman AS, Quon MJ.; Front Physiol (2021) 12:601894. Abstract/Full Text
Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism.: Grewal S, Fosam A, Chalk L, Deven A, Suzuki M, Correa RR, Blau JE, Demidowich AP, Stratakis CA, Muniyappa R.; Endocrine (2021 Apr) 72:96-103. Abstract/Full Text
Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin.: Lightbourne M, Wolska A, Abel BS, Rother KI, Walter M, Kushchayeva Y, Auh S, Shamburek RD, Remaley AT, Muniyappa R, Brown RJ.; J Endocr Soc (2021 Feb 1) 5:bvaa191. Abstract/Full Text
Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course.: Bansal R, Gubbi S, Muniyappa R.; Endocrinology (2020 Oct 1) 161. Abstract/Full Text
Diabetes, Obesity, and Risk Prediction of Severe COVID-19.: Muniyappa R, Wilkins KJ.; J Clin Endocrinol Metab (2020 Oct 1) 105. Abstract/Full Text
A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic.: Korytkowski M, Antinori-Lent K, Drincic A, Hirsch IB, McDonnell ME, Rushakoff R, Muniyappa R.; J Clin Endocrinol Metab (2020 Sep 1) 105. Abstract/Full Text
Endothelial dysfunction due to selective insulin resistance in vascular endothelium: insights from mechanistic modeling.: Muniyappa R, Chen H, Montagnani M, Sherman A, Quon MJ.; Am J Physiol Endocrinol Metab (2020 Sep 1) 319:E629-E646. Abstract/Full Text
Increased β-Cell Responsivity Independent of Insulin Sensitivity in Healthy African American Adults.: Armiyaw L, Sarcone C, Fosam A, Muniyappa R.; J Clin Endocrinol Metab (2020 Jul 1) 105:e2429-38. Abstract/Full Text
COVID-19 pandemic, coronaviruses, and diabetes mellitus.: Muniyappa R, Gubbi S.; Am J Physiol Endocrinol Metab (2020 May 1) 318:E736-E741. Abstract/Full Text
Reduced Insulin Clearance and Insulin-Degrading Enzyme Activity Contribute to Hyperinsulinemia in African Americans.: Fosam A, Sikder S, Abel BS, Tella SH, Walter MF, Mari A, Muniyappa R.; J Clin Endocrinol Metab (2020 Apr 1) 105:e1835-46. Abstract/Full Text
Metabolomic Analysis of the Effects of Leptin Replacement Therapy in Patients with Lipodystrophy.: Grewal S, Gubbi S, Fosam A, Sedmak C, Sikder S, Talluru H, Brown RJ, Muniyappa R.; J Endocr Soc (2020 Jan 1) 4:bvz022. Abstract/Full Text
Effects of growth hormone administration on luteinizing hormone secretion in healthy older men and women.: Muniyappa R, Sullivan SD, Tella SH, Abel BS, Harman SM, Blackman MR.; Physiol Rep (2017 Dec) 5. Abstract/Full Text
Plasma serpinB1 is related to insulin sensitivity but not pancreatic β-Cell function in non-diabetic adults.: Glicksman M, Asthana A, Abel BS, Walter MF, Skarulis MC, Muniyappa R.; Physiol Rep (2017 Mar) 5. Abstract/Full Text
Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy.: Muniyappa R, Abel BS, Asthana A, Walter MF, Cochran EK, Remaley AT, Skarulis MC, Gorden P, Brown RJ.; J Clin Lipidol (2017 Mar-Apr) 11:543-550. Abstract/Full Text
Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients.: Levenson AE, Haas ME, Miao J, Brown RJ, de Ferranti SD, Muniyappa R, Biddinger SB.; Endocrinology (2016 Apr) 157:1421-9. Abstract/Full Text

Last Reviewed July 2023